Jubilant Pharmova arm gets tentative USFDA approval for Pantoprazole Oral Suspension
Jubilant Pharmova has announced that the company, through its subsidiary, has received tentative approval for Pantoprazole Sodium Delayed Release Oral Suspension. The Noida-based company announced in an exchange filing today (June 26) that after the completion of the pre-approval inspection (PAI) conducted by the United States Food and Drug Administration (USFDA) at the Solid Dosage … Read more